Develops drugs for rare genetic kidney diseases.
Dec 2025Revenue $0.00/yrExpenses $6.44M/yr
No trendCash runway ≈ 3.9 years from Jun 2026
Figures by year
When will Eloxx Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $6.44M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $6.44M | −$6.44M |
| Dec 2024 | $6.36M | $8.83M | −$2.47M |
| Dec 2023 | $0.00 | $17.3M | −$17.3M |
| Jun 2014 | $182K | $9.33M | −$9.15M |
| Jun 2013 | $7.82K | $4.66M | −$4.65M |
| Jun 2012 | $200K | $5.61M | −$5.41M |
| Jun 2010 | $140K | $4.99M | −$4.85M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.